Article
ATRX loss promotes tumor growth and impairs nonhomologous end joining DNA repair in glioma.
Science translational medicine - 2 Mar 2016
Koschmann Carl, Calinescu Anda-Alexandra, Nunez Felipe J, Mackay Alan, Fazal-Salom Janet, Thomas Daniel, Mendez Flor, Kamran Neha, Dzaman Marta, Mulpuri Lakshman, Krasinkiewicz Johnathon, Doherty Robert, Lemons Rosemary, Brosnan-Cashman Jacqueline A, Li Youping, Roh Soyeon, Zhao Lili, Appelman Henry, Ferguson David, Gorbunova Vera, Meeker Alan, Jones Chris, Lowenstein Pedro R, Castro Maria G
Abstract excerpt
Recent work in human glioblastoma (GBM) has documented recurrent mutations in the histone chaperone protein ATRX. We developed an animal model of ATRX-deficient GBM and showed that loss of ATRX reduces median survival and increases genetic instability. Further, analysis of genome-wide data for human gliomas showed that ATRX mutation is associated with increased mutation rate at the single-nucleotide variant (SNV)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
